Figure 5.The nomogram model developed for predicting GBM patients’ prognosis. (A, B) Univariate and multivariate Cox regression analyses of the integration of risk scores and clinical parameters. (C) Development of a prognostic nomogram model for estimating GBM patients’ prognosis. (D) Calibration curve of the nomogram model at 3-, 5-, and 7-year. (E) Gene set enrichment analysis (GSEA) results, indicating the cytokine-cytokine receptor interaction, and JAK-STAT signaling pathway.
